Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Fujifilm, Takeda Pharmaceutical to Jointly Research iPS Cell-Based Regenerative Medicine

Filed Under: Industry, Pharma Tagged With: , , , , , , ,

Fujifilm Holdings Corp. (TYO:4901) and Takeda Pharmaceutical Co. Ltd. (TYO:4502) recently announced the start of joint research into regenerative medicine…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…